Furthermore, evidence from animal models, human cancer syndromes and immunohistochemical staining patterns in human endocrine tumors suggest that PI3K/Akt signaling may contribute to tumor progression, and, may even play a role in tumor initiation in some situations. This evidence concerns the gene PIK3CB and malignant endocrine neoplasm.